Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zydus Lifesciences has informed the stock exchanges that its Board of Directors will meet on Monday, February 9, 2026. The key agenda item is the approval of unaudited financial results for the quarter and nine months ended December 31, 2025 (Q3 FY26). The insider trading window has been closed until February 11, 2026, and will reopen on February 12, 2026. This is a routine regulatory disclosure made under SEBI Listing Regulations. No financial figures have been disclosed in this notice.
This is a pre-results intimation with no direct price impact. Investors should mark February 9, 2026, for the Q3 FY26 earnings announcement, which could move the stock based on the actual numbers. The closed trading window is standard procedure and restricts insiders from trading until 48 hours after results are published.